Joseph W. Venslavsky

Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3<i>S</i>)-3-piperidinylmethyl]oxy}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase

Dirk A. Heerding, Nelson Rhodes, Jack D. Leber et al. · Journal of Medicinal Chemistry · 2008 · 154 citations · Full text

Cell Death, Akt Kinase, Molecular Pharmacology +20

Orally Active and Potent Inhibitors of γ-Aminobutyric Acid Uptake

Fadia E. Ali, William E. Bondinell, Penelope A. Dandridge et al. · Journal of Medicinal Chemistry · 1985 · 130 citations · Full text

Pharmacotherapy, Experimental Pharmacology, Molecular Pharmacology +16

Discovery of Orally Active Nonpeptide Vitronectin Receptor Antagonists Based on a 2-Benzazepine Gly-Asp Mimetic

William H. Miller, Doreen Alberts, Pradip K. Bhatnagar et al. · Journal of Medicinal Chemistry · 1999 · 116 citations · Full text

Pharmacotherapy, Experimental Pharmacology, Pharmacodynamic Modeling +16

Potent, Selective, Orally Active 3-Oxo-1,4-benzodiazepine GPIIb/IIIa Integrin Antagonists

James M. Samanen, Fadia E. Ali, Linda S. Barton et al. · Journal of Medicinal Chemistry · 1996 · 72 citations · Full text

Altmetric Attention Score, Pharmacotherapy, Experimental Pharmacology +17

Conformational Preferences in a Benzodiazepine Series of Potent Nonpeptide Fibrinogen Receptor Antagonists

Richard M. Keenan, James F. Callahan, James M. Samanen et al. · Journal of Medicinal Chemistry · 1999 · 53 citations · Full text